EUVIMEDEUVIMED entdecken
Crossref

Delays in treatment initiation and conclusion in women with stage IA to IIIB cervical cancer: A survival study in a hospital-based cohort from a developing country

Ilce Ferreira da Silva, Ileia Ferreira da Silva, Valéria Saraceni, Rosalina Jorge Koifman

Cancer Epidemiology · 2023-10 · 86 · 102450

DOI: 10.1016/j.canep.2023.102450 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Epidemiology, 2023-10. Verfasst von Ilce Ferreira da Silva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Quantitative Methods in Health, National School of public Health, Oswaldo Cruz Foundation, Brazil; Graduate Program of…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Time-to-Treatment. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Instituto Nacional do Câncer, Ministério da Saúde, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: To evaluate the effect of delays in stage IA to IIIB cervical cancer treatment initiation and conclusion on hospital-based survival among Brazilian women. METHODS: A retrospective follow-up study was conducted in a stage IA to IIIB cervical cancer cohort treated from 2012 and 2014 and followed until December 31, 2017 in Rio de Janeiro. Delay in treatment initiation definition was defined based on the Brazilian law of 60 days for treatment initiation after diagnosis. Delay in treatment conclusion was defined based on the literature and sample distributions: 200 days. The endpoint was death(from all causes or cervical cancer). Death causes and dates were obtained by a record linkage procedure between the hospital cancer registry and the Mortality Information System. Global 36-month survival and HRs were estimated by the KaplanMeier method and proportional Cox regression models, respectively. RESULTS: From 865 patients, 269(31.1%) died over the median follow-up time of 27 months. Delay on treatment initiation(>60-days) was 92.8%, while the delay in treatment conclusion(>120 days) was 87.5%. Overall survival was 61.3% ( 90-days had 53.3%. Delays in treatment conclusion significantly reduced survival[72.2%( 200-days)]. Multivariate analysis showed that delays in treatment initiation did not affect 36-month death risk. Compared to women concluding treatment in 200-days showed increases in death risk of 89%(95%CI:1.10-3.24) and 111%(95%CI:1.31-3.39), respectively, regardless of age, stage, treatment protocol, and time to treatment initiation. CONCLUSION: Delays in cervical cancer treatment conclusion (but not treatment initiation) affected 36-month survival and death risk among Brazilians.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsTime-to-TreatmentHumansFemaleMiddle AgedRetrospective StudiesBrazilAdultNeoplasm StagingFollow-Up StudiesAgedDeveloping Countries

Stichwörter der Autor:innen

BrazilCervical cancerDelays in treatmentEpidemiologyHospital-based cohort

Autor:innen und Institutionen

  • Department of Epidemiology and Quantitative Methods in Health, National School of public Health, Oswaldo Cruz Foundation, Brazil; Graduate Program of Environmental Public Health, Nation al School of public Health, Oswal…
  • Graduate Program of Environmental Public Health, Nation al School of public Health, Oswaldo Cruz Foundation, Brazil.
  • Superintendence of Health Surveillance, Municipal Health Secretariat of Rio de Janeiro, Rio de Janeiro, Brazil.

Förderung

  • Instituto Nacional do Câncer, Ministério da Saúde
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Zitieren

APA

da Silva, I. F., da Silva, I. F., Saraceni, V., & Koifman, R. J. (2023). Delays in treatment initiation and conclusion in women with stage IA to IIIB cervical cancer: A survival study in a hospital-based cohort from a developing country. Cancer Epidemiology, 86, 102450. https://doi.org/10.1016/j.canep.2023.102450

Vancouver

da Silva IF, da Silva IF, Saraceni V, Koifman RJ. Delays in treatment initiation and conclusion in women with stage IA to IIIB cervical cancer: A survival study in a hospital-based cohort from a developing country. Cancer Epidemiology. 2023;86:102450. doi:10.1016/j.canep.2023.102450

BibTeX
@article{daSilva2023,
  author = {da Silva, Ilce Ferreira and da Silva, Ileia Ferreira and Saraceni, Valéria and Koifman, Rosalina Jorge},
  title = {Delays in treatment initiation and conclusion in women with stage IA to IIIB cervical cancer: A survival study in a hospital-based cohort from a developing country},
  journal = {Cancer Epidemiology},
  year = {2023},
  volume = {86},
  pages = {102450},
  doi = {10.1016/j.canep.2023.102450}
}
Kostenlos starten →